Skip to main content
. Author manuscript; available in PMC: 2015 Oct 8.
Published in final edited form as: Eur J Clin Nutr. 2015 Jan 28;69(10):1145–1150. doi: 10.1038/ejcn.2014.295

Table 5.

Associations between folate intake and risk of preeclampsia by severity of preeclampsia (N=1059), Urban China, 2010–2012

Folate intake Controls Mild preeclampsia (n = 137)
Severe preeclampsia (n = 216)
Cases ORa (95% CI) Cases ORa (95% CI)
Folic acid supplements
 Nonusers 150 43 1 72 1
 Users 556 94 0.50 (0.30, 0.81) 144 0.69 (0.46, 1.04)
Dietary folate intake (μg/day)
 Before conception
  Q1 (<116.0) 176 27 1 66 1
  Q2 (116.0, 152.2) 177 31 1.19 (0.65, 2.17) 47 0.86 (0.53, 1.40)
  Q3 (152.2, 229.9) 177 47 1.85 (1.05, 3.26) 64 0.98 (0.62, 1.56)
  Q4 (≥229.9) 176 32 1.13 (0.61, 2.07) 39 0.63 (0.39, 1.05)
  P for trend 0.38 0.15
 During pregnancy
  Q1 (<151.6) 176 27 1 70 1
  Q2 (151.6, 194.2) 178 32 1.30 (0.71, 2.39) 47 0.85 (0.52, 1.38)
  Q3 (194.2, 274.4) 176 41 1.71 (0.95, 3.08) 60 0.98 (0.62, 1.57)
  Q4 (≥274.4) 176 37 1.25 (0.69, 2.27) 39 0.52 (0.31, 0.87)
  P for trend 0.36 0.037

Abbreviations: CI, confidence interval; OR, odds ratio.

a

Adjusted for maternal age, education level, maternal diabetes, prepregnancy BMI, weight gain during pregnancy, family monthly income per capita, multiple birth, maternal employment during pregnancy, parity, history of gestational hypertension and dietary folate intake or folic acid supplements.